Written by the Nuvirox Research Team
Key Points
- In a 2023 double-blind RCT (n=44), intra-articular ozone injections performed about as well as hyaluronic acid injections for knee osteoarthritis pain — neither beat the other.
- A 2018 meta-analysis of multiple RCTs reached the same conclusion: ozone and hyaluronic acid produce comparable pain and function improvements at 6 months.
- Ozone is not a cure for osteoarthritis — it's one option among several injectable therapies, with a similar (modest, temporary) effect size to the injections it's usually compared against.
Short answer: yes, ozone injections appear to relieve knee osteoarthritis pain about as well as hyaluronic acid injections do — which is a real but modest effect, not a cure. The honest framing is "comparable to an existing option," not "a breakthrough alternative."
What is intra-articular ozone therapy?
Ozone therapy for knee osteoarthritis involves injecting a small volume of medical-grade oxygen-ozone gas mixture directly into the knee joint, typically across a short series of weekly sessions. The proposed mechanism involves ozone's effect on oxidative signaling and local inflammatory mediators within the joint capsule, distinct from hyaluronic acid's role as a lubricating viscosupplement. It's used in pain clinics in parts of Europe, the Middle East, and Asia, and has drawn interest in the U.S. as an alternative to corticosteroid or hyaluronic acid (HA) injections.
How does ozone compare to hyaluronic acid in actual trials?
Head-to-head, not particularly differently. A 2023 double-blind randomized controlled trial gave real data on this exact comparison, and multiple prior meta-analyses of RCTs comparing the two have landed on the same conclusion: similar improvement, no clear winner.
What human studies actually show
Direct ozone vs. hyaluronic acid RCT (2023): A double-blind randomized trial enrolled 52 patients with knee osteoarthritis (44 completed), assigning them to three weekly intra-articular injections of either an oxygen-ozone mixture or sodium hyaluronate. WOMAC pain scores dropped from a baseline of roughly 6.8–7.3 to about 3.7–4.4 (ozone) and 2.8–3.9 (HA) across the 1- to 6-month follow-up window. The authors explicitly reported "no significant differences were observed between groups at the various time intervals." Adverse events were mild and self-limiting in both groups (11% ozone, 10% HA).
Meta-analysis of multiple trials: A published meta-analysis pooling several randomized trials on intra-articular ozone versus hyaluronic acid for knee osteoarthritis similarly found comparable clinical outcomes between the two approaches, reinforcing that ozone isn't outperforming the standard viscosupplementation option — it's roughly matching it.
The honest limiting finding: Neither treatment eliminated pain. Both groups still reported meaningful residual WOMAC pain scores at 6 months, and the improvement pattern for both treatments follows the well-known trajectory of injectable knee therapies generally: a real but partial and temporary effect, not a structural fix for the underlying joint degeneration.
How does ozone therapy's mechanism differ from hyaluronic acid's?
The two therapies work through genuinely different mechanisms, which is part of why researchers keep testing them head-to-head rather than assuming one obviously supersedes the other. Hyaluronic acid injections aim to restore some of the joint's natural lubricating viscosity, a physical, mechanical rationale. Ozone's proposed mechanism is biochemical: a controlled, low-concentration oxidative stimulus is thought to trigger antioxidant enzyme upregulation and modulate local inflammatory cytokine signaling within the joint. Neither mechanism has been shown to regenerate cartilage tissue itself, which is consistent with why both approaches produce similar, partial, and ultimately temporary symptom relief rather than disease reversal.
What ozone injections won't do
They won't regenerate cartilage or reverse osteoarthritis' structural progression — none of the injectable options studied here (ozone or HA) have been shown to do that. They also require repeated administration by a trained clinician; this isn't a self-administered or over-the-counter therapy. See a doctor if knee pain is accompanied by significant swelling, warmth, or instability, since those symptoms warrant an exam and possibly imaging before considering any injection therapy, ozone included.
Dosing and treatment timeline seen in the research
The RCT protocol above used three weekly intra-articular injections, with pain reduction becoming apparent by the one-month mark and partially maintained through six months before beginning to wane — a timeline consistent with other injectable knee osteoarthritis therapies, including corticosteroids and HA.
Frequently asked questions
Is ozone therapy for knees FDA-approved?
Ozone gas itself is not FDA-approved as a medical treatment in the U.S. the way hyaluronic acid injections are; availability varies by clinic and jurisdiction, so ask any provider directly about their regulatory basis.
How long does the pain relief from ozone injections last?
In the RCT reviewed above, benefit was present at 6 months but had already started fading from its 1-month peak — similar to the typical HA injection timeline.
Is ozone therapy safer than steroid injections?
This article didn't review steroid-vs-ozone data specifically; the trials here compared ozone to hyaluronic acid, where both had low, similar rates of mild adverse events.
Can ozone injections be combined with other joint treatments?
This wasn't specifically tested in the trials reviewed here; any combination approach — with physical therapy, weight management, or oral joint-support ingredients — is a conversation to have with the treating clinician rather than something these particular studies addressed.
Does the concentration of ozone gas used matter?
The RCT reviewed here used a 10 μg/mL concentration across three weekly injections; different clinics and studies have used varying concentrations, which is part of why standardized protocol comparisons remain an active area of research.
For people exploring non-injectable joint-support options in parallel, our review of boswellia and curcumin research for joint pain covers orally-dosed ingredients with their own human trial data, and if genetics play into your osteoarthritis risk, see whether osteoarthritis is hereditary. Cost is also a practical factor worth weighing: intra-articular injections of either type require a clinician's office visit and are typically billed per session, so the choice between ozone and hyaluronic acid may reasonably come down to what your specific insurance plan covers or what a local provider is trained and equipped to administer, rather than a clear efficacy edge from the trial data itself.
FROM NUVIROX
Why we formulated Joint+ Restore.
Joint+ Restore is formulated to support joint comfort, flexible movement, and healthy cartilage maintenance as part of a daily routine — not as a treatment for any diagnosed condition. We're currently updating the formula and aren't publishing specific ingredient amounts here while that work is underway, but the same structure/function goals guide every version.
Every Nuvirox order is backed by a 60-day money-back guarantee — long enough to actually evaluate it the way the research on joint-support ingredients generally suggests you should.
Learn more about Joint+ Restore →The bottom line: Ozone injections for knee osteoarthritis aren't a miracle alternative to hyaluronic acid — the best trial evidence says they're roughly equivalent, with both producing partial, temporary pain relief rather than a cure. If you're deciding between the two with a clinician, the choice may come down to availability, cost, and provider experience rather than one being clearly superior. Anyone considering either option should go in with calibrated expectations: meaningful pain reduction for several months, not a permanent resolution of osteoarthritis.
References
- Isik M, et al. "Ozone Therapy versus Hyaluronic Acid Injections for Pain Relief in Patients with Knee Osteoarthritis: Preliminary Findings on Molecular and Clinical Outcomes from a Randomized Controlled Trial." PMC10218112, 2023.
- Meta-analysis: "Intra-articular oxygen-ozone versus hyaluronic acid in knee osteoarthritis: A meta-analysis of randomized controlled trials." PubMed 30170178, 2018.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.